NeuroOne Medical Technologies Corporation

NMTC62

Penny Stock

$0.84arrow_drop_up1.44%$0.01

Penny Stock

NMTC62

$0.84

arrow_drop_up1.44%$0.01

Penny Stock

Performance History

Key Stats
Open	$0.86
Prev. Close	$0.84
EPS	-0.48
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$25.57M
PE Ratio	-

	LOW	HIGH
Day Range	0.81	0.86
52 Week Range	0.60	2.00

Ratios







EPS	-0.48

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About NeuroOne Medical Technologies Corporation (NMTC)

NeuroOne Medical Technologies Corporation (NMTC) is a medical device company that focuses on neuromodulation for the treatment of neurological disorders. The company is dedicated to developing innovative solutions that provide targeted therapies for patients suffering from conditions like epilepsy, Parkinson's disease, and chronic pain. With a strong commitment to research and development, NMTC strives to enhance the quality of life for individuals dealing with these debilitating disorders.

NMTC offers a range of medical devices that utilize advanced technologies to deliver precise and personalized treatment options. Their flagship product, the EvoTM Cortical Electrode, is designed to help surgeons accurately locate the origin of neurological disorders and target specific areas for treatment. This electrode is minimally invasive and allows for improved diagnostics, leading to more effective treatment outcomes. Additionally, NMTC's latest product, the sEEG Depth Electrode, enables deep brain mapping and is particularly valuable for patients with epilepsy.

Websitecall_made

Sector: Healthcare
Industry: Medical Devices
CEO: Mr. David A. Rosa M.D.
Headquarters: Eden Prairie
Employees: 15
Exchange: NASDAQ

add NeuroOne Medical Technologies Corporation to watchlist

Keep an eye on NeuroOne Medical Technologies Corporation

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is NeuroOne Medical Technologies Corporation's (NMTC) price per share?

The current price per share for NeuroOne Medical Technologies Corporation (NMTC) is $0.84. The stock has seen a price change of $0.01 recently, indicating a 1.45% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for NeuroOne Medical Technologies Corporation (NMTC)?

For NeuroOne Medical Technologies Corporation (NMTC), the 52-week high is $2, which is 137.53% from the current price. The 52-week low is $0.6, the current price is 39.87% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is NeuroOne Medical Technologies Corporation (NMTC) a growth stock?

NeuroOne Medical Technologies Corporation (NMTC) has shown an average price growth of 0.41% over the past three years. It has received a score of 35 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying NeuroOne Medical Technologies Corporation as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is NeuroOne Medical Technologies Corporation (NMTC) stock price performance year to date (YTD)?

As of the latest data, NeuroOne Medical Technologies Corporation (NMTC) has a year-to-date price change of -48.02%. Over the past month, the stock has experienced a price change of 15.34%. Over the last three months, the change has been -4.33%. Over the past six months, the figure is -20.57%.

help

Is NeuroOne Medical Technologies Corporation (NMTC) a profitable company?

NeuroOne Medical Technologies Corporation (NMTC) has a net income of -$11.86M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 23.38% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -338.34% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $1.95M, although specific revenue growth data is currently not available. The gross profit is $456.52K. Operating income is noted at -$11.96M. Furthermore, the EBITDA is -$11.99M.

help

What is the market capitalization of NeuroOne Medical Technologies Corporation (NMTC)?

NeuroOne Medical Technologies Corporation (NMTC) has a market capitalization of $25.57M. The average daily trading volume is 45.83K, indicating the stock's liquidity and investor engagement.